BioXcel Therapeutics, Inc. (BTAI) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for BioXcel Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.28x | -0.25x | -0.48x | -3.63x | -5.01x | -12.19x |
| P/B Ratio | -0.20x | -0.16x | -1.52x | 7.84x | 2.42x | 4.85x |
| P/S Ratio | 30.42x | 6.69x | 62.27x | 1604.70x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 27.7% | 5.4% | 8.7% | 94.7% | 0.0% | 0.0% |
| Operating Margin | -7742.2% | -2967.6% | -12448.0% | -42572.0% | 0.0% | 0.0% |
| Net Margin | -10887.4% | -2630.1% | -12974.9% | -44201.9% | 0.0% | 0.0% |
| EBITDA Margin | -7695.5% | -1948.9% | -11987.0% | -41924.5% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 0.83x | 1.68x | 2.65x | 6.17x | 14.21x | 18.33x |
| Quick Ratio | 0.82x | 1.65x | 2.57x | 6.11x | 14.21x | 18.33x |
| Leverage | ||||||
| Debt/Equity | -1.15x | -1.11x | -1.79x | 1.23x | 0.01x | 0.01x |
YoY = year-over-year change. Source: FMP..